Related by context. Frequent words. (Click for all words.) 71 EORTC 65 neoadjuvant 63 neoadjuvant chemotherapy 61 placebo controlled clinical 60 National Surgical Adjuvant 60 HER2 positive metastatic breast 60 subgroup analyzes 59 multicenter 59 chemoradiation 59 randomized Phase III 59 ECOG 59 multicenter randomized 59 Cooperative Oncology 58 multicenter study 58 noninferiority 58 sunitinib 58 Thoracic Oncology 58 evaluable patients 58 axitinib 58 prospective randomized controlled 57 decitabine 57 J Clin Oncol 57 nab paclitaxel 57 invasive bladder 57 multicenter clinical 57 seliciclib 57 lymph node involvement 57 randomized controlled clinical 57 randomized trials 57 ASCO Annual Meeting 56 tocilizumab 56 retrospective cohort study 56 substudy 56 imetelstat 56 CA4P 56 AASLD 56 adjuvant therapy 56 adjuvant chemotherapy 56 MSKCC 56 CAPRISA 56 tipranavir 56 distant metastases 55 relapsed refractory multiple myeloma 55 secondary efficacy endpoints 55 tesmilifene 55 multicentre 55 meta analyzes 55 AACR NCI EORTC 55 San Antonio Breast Cancer 55 aflibercept 55 TASQ 55 SBRT 55 antitumor activity 55 histologic 55 prognostic factors 55 mg kg dose 55 xenograft models 55 soft tissue sarcomas 55 metastatic renal cell carcinoma 55 COPAXONE R 55 vandetanib 54 RECIST criteria 54 randomized clinical 54 randomized controlled clinical trials 54 bronchial thermoplasty 54 MDV# 54 allogeneic stem cell 54 Phase III randomized 54 Neuradiab 54 Neck Cancer 54 neoplastic 54 RCTs 54 virologic response 54 FDG PET 54 liver metastases 54 CYPHER ® Stent 54 dose escalation 54 renal transplantation 54 sustained virologic response 54 Ann Intern Med 54 azacitidine 54 adalimumab 54 GVAX 54 tamoxifen therapy 54 anastrozole 54 Pharmacokinetic 54 TORISEL 54 romidepsin 54 PCa 54 evaluable 54 TIMI 54 recurrent prostate cancer 54 Clinical Oncology 53 AP# [003] 53 resistant ovarian cancer 53 PCA3 53 NCI 53 Arch Intern Med 53 Phase 2a trial 53 ADHF 53 TNFerade